Product Information

ANORO ELLIPTA 62.5-25 MCG INH is a brand product labeled by GlaxoSmithKline LLC, priced at $7.8006 per EA under NDC 00173086910. Its NADAC has been published 623 times since Jul 23, 2014.

ANORO ELLIPTA 62.5-25 MCG INH

umeclidinium bromide and vilanterol trifenatate
$7.8006per EA

Strength

62.5; 25 ug/1; ug/1

NDC

00173086910

Classification

Brand

Dosage Form

POWDER

Route

RESPIRATORY (INHALATION)

Last Updated

6/17/2026

Approval Type

New Drug (NDA)

FDA Application

NDA203975

On Market Since

1/31/2014

Pharmacological Classes

Adrenergic beta2-Agonists
Anticholinergic
Cholinergic Antagonists
beta2-Adrenergic Agonist

Price Statistics

The NADAC for ANORO ELLIPTA 62.5-25 MCG INH has been published 623 times since Jul 23, 2014, and over the history we have for it it has risen 75.3%. The table below summarizes its recorded NADAC range and movement.

Current price$7.8006 per EA
All-time high$7.8208 (May 14, 2025)
All-time low$4.4511 (Jul 23, 2014)
52-week high$7.8130
52-week low$7.8006
Median price$6.7467
Average price$6.5157
Largest weekly change+8.0% (Jan 10, 2018)
Weeks tracked623
Tracking sinceJul 23, 2014

Price History

1W

0.0%

1M

-0.0%

3M

-0.2%

6M

-0.2%

1Y

-0.1%

3Y

+5.8%

5Y

+12.4%

All

+75.3%

Generic Alternatives

The matcher finds 2 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 2 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 38% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of ANORO ELLIPTA 62.5-25 MCG INH?

The current National Average Drug Acquisition Cost (NADAC) for ANORO ELLIPTA 62.5-25 MCG INH, manufactured by GlaxoSmithKline LLC, is $7.8006 per EA (NDC 00173086910), effective Jun 24, 2026.

How has the price of ANORO ELLIPTA 62.5-25 MCG INH changed over time?

Over the history we have for it, the NADAC for ANORO ELLIPTA 62.5-25 MCG INH has risen 75.3%. It has been tracked across 623 weekly CMS publications since Jul 23, 2014.

What are the highest and lowest recorded NADAC prices for ANORO ELLIPTA 62.5-25 MCG INH?

Since Jul 23, 2014, the NADAC for ANORO ELLIPTA 62.5-25 MCG INH has ranged from a low of $4.4511 (Jul 23, 2014) to a high of $7.8208 (May 14, 2025), with a median of $6.7467 per EA.

Are there cheaper alternatives to ANORO ELLIPTA 62.5-25 MCG INH?

Yes. 2 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, UMECLIDINIUM-VILANTEROL ELLIPTA 62.5-25 MCG INH, is $4.8733 per EA — about 38% below ANORO ELLIPTA 62.5-25 MCG INH.

Who manufactures ANORO ELLIPTA 62.5-25 MCG INH?

ANORO ELLIPTA 62.5-25 MCG INH (NDC 00173086910) is labeled by GlaxoSmithKline LLC, and CMS classifies it as a brand product.